NCT00598962View on ClinicalTrials.gov

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 1994

Primary Completion Date

November 30, 2006

Study Completion Date

May 18, 2017

Conditions
Mycobacterium Avium Complex
Interventions
DRUG

Azithromycin

Dosage dependent on clinical factors such as age, weight and patient-specific health status

DRUG

Rifabutin/rifampin

Trial Locations (1)

75708

The University of Texas Health Science Center at Tyler, Tyler

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

The University of Texas Health Science Center at Tyler

OTHER